KRAS G12C inhibitor 34
KRAS G12C inhibitor 34 is a KRAS G12C inhibitor extracted from patent WO2021239058A1, compound Z1. KRAS G12C inhibitor 34 can be used for the research of cancer[1].
Product Specifications
CAS Number
2749948-26-1
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-34.html
Solubility
10 mM in DMSO
Smiles
O=C1N2[C@@](CN(C(C=C)=O)CC2)([H])COC3=C(Cl)C(C4=C(C)C=CC5=C4C=NN5)=CC(NC6=CC=CC=C6C(C)C)=C13
Molecular Formula
C32H32ClN5O3
Molecular Weight
570.08
References & Citations
[1]Zhou FS, et, al. Fused tricyclic compound, pharmaceutical composition thereof, and use thereof. WO2021239058A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042848-100 1x 100 µL
Fibronectin (Fn-3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741231-100 1x 100 µL
Eosinophil Peroxidase (AHE-1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470994-100 1x 100 µL
TNF alpha (J2D10), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details